Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression to reduce sensitivity to cisplatin in bladder cancer

Cigarette Smoke Containing Acrolein Contributes to Cisplatin Resistance in Human Bladder Cancers through the Regulation of HER2 Pathway or FGFR3 Pathway

(2022) Jian-Hua Hong et al.   MOLECULAR CANCER THERAPEUTICS

Histone Methylases and Demethylases Regulating Antagonistic Methyl Marks: Changes Occurring in Cancer

(2022) Joyce Taylor-Papadimitriou et al.   Cells

CBX7 represses the POU2F2 to inhibit the PD-L1 expression and regulate the immune response in bladder cancer

(2022) Weigang Ren et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Fibroblast growth factor receptor: A systematic review and meta-analysis of prognostic value and therapeutic options in patients with urothelial bladder carcinoma

(2021) Mehdi Kardoust Parizi et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Fibroblast growth factor receptor (FGFR) gene: pathogenesis and treatment implications in urothelial carcinoma of the bladder

(2021) Khaleel I Al-Obaidy et al.   JOURNAL OF CLINICAL PATHOLOGY

FGFR3 phosphorylates EGFR to promote cisplatin-resistance in ovarian cancer

(2021) Jing Zhao et al.   BIOCHEMICAL PHARMACOLOGY

FGFR3 Destabilizes PD-L1 via NEDD4 to Control T-cell–Mediated Bladder Cancer Immune Surveillance

(2021) Weiqiang Jing et al.   CANCER RESEARCH

Fibroblast growth factor receptor fusions in cancer: opportunities and challenges

(2021) Lingfeng Chen et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

A Polycomb domain found in committed cells impairs differentiation when introduced into PRC1 in pluripotent cells

(2021) Elizabeth S. Jaensch et al.   MOLECULAR CELL

PDE4B Induces Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Is Transcriptionally Suppressed by CBX7

(2021) Zhengnan Huang et al.   Frontiers in Cell and Developmental Biology

LncRNA KCNQ1OT1 accelerates fracture healing via modulating miR‐701‐3p/FGFR3 axis

(2020) Lang Chen et al.   FASEB JOURNAL

Targets for Therapy of Bladder Cancer

(2020) Christof Seidl   SEMINARS IN NUCLEAR MEDICINE

MicroRNA-99a Suppresses Breast Cancer Progression by Targeting FGFR3

(2020) Xinghua Long et al.   Frontiers in Oncology

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

(2020) J. Alfred Witjes et al.   EUROPEAN UROLOGY

Treatment of muscle‐invasive and advanced bladder cancer in 2020

(2020) Vaibhav G. Patel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†

(2020) Bas W.G. van Rhijn et al.   EUROPEAN UROLOGY

EZH2: a novel target for cancer treatment

(2020) Ran Duan et al.   Journal of Hematology & Oncology

Bladder Cancer

(2020) Andrew T. Lenis et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Suppressing UPR-dependent overactivation of FGFR3 signaling ameliorates SLC26A2-deficient chondrodysplasias

(2019) Chao Zheng et al.   EBioMedicine

Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression

(2019) Weipu Mao et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Molecular and histopathology directed therapy for advanced bladder cancer

(2019) Constantine Alifrangis et al.   Nature Reviews Urology

ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer

(2019) Erica di Martino et al.   Scientific Reports

Erdafitinib for the treatment of metastatic bladder cancer

(2019) Kamaneh Montazeri et al.   Expert Review of Clinical Pharmacology

CBX7 regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-κB-miR-21 pathways

(2018) Su-Jie Ni et al.   Journal of Hematology & Oncology

miR-24-3p/FGFR3 Signaling as a Novel Axis Is Involved in Epithelial-Mesenchymal Transition and Regulates Lung Adenocarcinoma Progression

(2018) Pengyu Jing et al.   Journal of Immunology Research

Somatic FGFR3 Mutations Distinguish a Subgroup of Muscle-Invasive Bladder Cancers with Response to Neoadjuvant Chemotherapy

(2018) Zhao Yang et al.   EBioMedicine

ChIP‐Atlas: a data‐mining suite powered by full integration of public ChIP‐seq data

(2018) Shinya Oki et al.   EMBO REPORTS

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study

(2018) Andrea Necchi et al.   JOURNAL OF CLINICAL ONCOLOGY

Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression

(2018) Xin Jin et al.   MOLECULAR CELL

Knockdown of retinoblastoma protein may sensitize glioma cells to cisplatin through inhibition of autophagy

(2016) Xiangyu Liu et al.   NEUROSCIENCE LETTERS

Up-Regulation of miR-9 Target CBX7 to Regulate Invasion Ability of Bladder Transitional Cell Carcinoma

(2015) Xiaojie Tong   MEDICAL SCIENCE MONITOR

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

(2014) Woonyoung Choi et al.   CANCER CELL

Cisplatin in cancer therapy: Molecular mechanisms of action

(2014) Shaloam Dasari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Fibroblast growth factor receptor-3 in urothelial tumorigenesis

(2012) Gopa Iyer et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status

(2011) Ruth L. Vinall et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

Asymmetric tyrosine kinase arrangements in activation or autophosphorylation of receptor tyrosine kinases

(2010) Jae Hyun Bae et al.   MOLECULES AND CELLS

Oncogenic role of fibroblast growth factor receptor 3 in tumorigenesis of urinary bladder cancer

(2010) Arshad A. Pandith et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Increased expression of miR-421 in human gastric carcinoma and its clinical association

(2009) Zhen Jiang et al.   JOURNAL OF GASTROENTEROLOGY